News Opinion Off Script Evoque and Patisiran: A Tale of Two Regulatory Journeys Sanjay Kaul, MD March 29, 2024
News Daily News ICD Benefits Hold Up for Modern-day Primary Prevention, but Questions Remain Todd Neale March 25, 2024
News Daily News Abiomed Recalls Labeling for Left-Sided Impella Pumps: FDA Caitlin E. Cox March 21, 2024
News Daily News Pay Now, Save Later: Intracoronary Imaging for PCI Cost-effective Over Lifetime Yael L. Maxwell March 18, 2024
News Daily News LAAO Over Meds in AF? Demographic, Clinical Factors Are at Play Todd Neale March 15, 2024
News Conference News CRT 2024 SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI L.A. McKeown March 15, 2024
News Daily News New Advice Released on Advanced Imaging for Evaluation of CV Infections Todd Neale March 14, 2024
News Conference News CRT 2024 Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction L.A. McKeown March 12, 2024
News Daily News Occupational Hazard? CTO Cases Drive Up Operators’ BP, Heart Rates Yael L. Maxwell March 11, 2024
News Conference News CRT 2024 Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis L.A. McKeown March 09, 2024
News Conference News THT 2024 Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF Michael O'Riordan March 08, 2024
News Conference News THT 2024 Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients Michael O'Riordan March 07, 2024
News Daily News Just a Few Thousand Steps Can Help Reduce CV Harms of Sitting Caitlin E. Cox March 06, 2024
News Conference News THT 2024 Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS Michael O'Riordan March 06, 2024
News Conference News THT 2024 Debating the Role of T-TEER in the Sickest Patients Michael O'Riordan March 05, 2024
News Daily News Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry Caitlin E. Cox March 01, 2024
News Daily News Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis L.A. McKeown March 01, 2024
News Daily News Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective Michael O'Riordan February 23, 2024